Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

GeneDx Holdings (WGS) Gross Margin: 2020-2025

Historic Gross Margin for GeneDx Holdings (WGS) over the last 6 years, with Sep 2025 value amounting to 72.40%.

  • GeneDx Holdings' Gross Margin rose 1019.00% to 72.40% in Q3 2025 from the same period last year, while for Sep 2025 it was 69.65%, marking a year-over-year increase of 1017.00%. This contributed to the annual value of 63.64% for FY2024, which is 1921.00% up from last year.
  • Latest data reveals that GeneDx Holdings reported Gross Margin of 72.40% as of Q3 2025, which was up 4.87% from 69.04% recorded in Q2 2025.
  • In the past 5 years, GeneDx Holdings' Gross Margin registered a high of 72.40% during Q3 2025, and its lowest value of -81.83% during Q2 2022.
  • Moreover, its 3-year median value for Gross Margin was 60.91% (2024), whereas its average is 57.79%.
  • Per our database at Business Quant, GeneDx Holdings' Gross Margin plummeted by 7,936bps in 2022 and then surged by 12,034bps in 2023.
  • GeneDx Holdings' Gross Margin (Quarterly) stood at -4.85% in 2021, then tumbled by 2,176bps to -26.61% in 2022, then surged by 8,017bps to 53.56% in 2023, then soared by 1,566bps to 69.22% in 2024, then soared by 1,019bps to 72.40% in 2025.
  • Its Gross Margin stands at 72.40% for Q3 2025, versus 69.04% for Q2 2025 and 67.13% for Q1 2025.